Wang, S.; Tai, Q.; Wang, K.; Zheng, J.; Guo, B.; Yang, F.; Wang, C.
Engineered Lipid Nanoparticles with Promoted Endosomal Escape and R283S-Mediated Stimulator of Interferon Genes (STING) Activation for Pancreatic Cancer Immunotherapy. Pharmaceutics 2026, 18, 760.
https://doi.org/10.3390/pharmaceutics18060760
AMA Style
Wang S, Tai Q, Wang K, Zheng J, Guo B, Yang F, Wang C.
Engineered Lipid Nanoparticles with Promoted Endosomal Escape and R283S-Mediated Stimulator of Interferon Genes (STING) Activation for Pancreatic Cancer Immunotherapy. Pharmaceutics. 2026; 18(6):760.
https://doi.org/10.3390/pharmaceutics18060760
Chicago/Turabian Style
Wang, Sizhen, Qiwei Tai, Kehui Wang, Jianyu Zheng, Beibei Guo, Feng Yang, and Chen Wang.
2026. "Engineered Lipid Nanoparticles with Promoted Endosomal Escape and R283S-Mediated Stimulator of Interferon Genes (STING) Activation for Pancreatic Cancer Immunotherapy" Pharmaceutics 18, no. 6: 760.
https://doi.org/10.3390/pharmaceutics18060760
APA Style
Wang, S., Tai, Q., Wang, K., Zheng, J., Guo, B., Yang, F., & Wang, C.
(2026). Engineered Lipid Nanoparticles with Promoted Endosomal Escape and R283S-Mediated Stimulator of Interferon Genes (STING) Activation for Pancreatic Cancer Immunotherapy. Pharmaceutics, 18(6), 760.
https://doi.org/10.3390/pharmaceutics18060760
